Skip to main content

Syneos Health, Inc.

SYNHDelisted
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001610950

Syneos Health, Inc. was delisted in 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.35B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
317
Q2 2023, +12 vs. previous quarter
13F value
$4.32B
Reported value at the end of Q2 2023
Superinvestors holding
2
At the end of Q2 2023

Superinvestors holding SYNH, Q2 2023

2 superinvestors report holding Syneos Health, Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Go to the superinvestors tab

Elliott Investment Management

Paul Singer

1.7%

Syneos Health, Inc.'s share of the portfolio

Shares
3,299,476
Value
$139.0M

Southeastern Asset Management (Longleaf)

Mason Hawkins

<0.1%

Syneos Health, Inc.'s share of the portfolio

Shares
19,655
Value
$828.3K

Latest insider trades

Open-market purchases and sales by Syneos Health, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 29, 2022 (view filing)Jul 281 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−1.00K$78.00−$78.2K−2.1%47.6K after
Jul 29, 2022 (view filing)Jul 281 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−500$78.00−$39.0K−5.1%9.34K after
Jul 22, 2022 (view filing)Jul 211 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−1.00K$76.00−$76.2K−2.0%48.6K after
Jul 22, 2022 (view filing)Jul 211 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−500$76.00−$38.0K−4.8%9.84K after
Jul 21, 2022 (view filing)Jul 201 dayOlefson JonathanGeneral Counsel & Corp SectySSaleClass A Common Stock−2.21K$75.00−$166.1K−8.1%25.3K after
Jul 20, 2022 (view filing)Jul 191 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−1.00K$74.00−$74.1K−2.0%49.6K after
Jul 20, 2022 (view filing)Jul 191 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−500$74.00−$37.0K−4.6%10.3K after
Jul 20, 2022 (view filing)Jul 182 daysKeefe MichelleChief Executive OfficerSSaleClass A Common Stock−8.33K$72.81−$606.7K−10.5%71.3K after
Jul 20, 2022 (view filing)Jul 182 daysMeggs Jason M.Chief Financial OfficerSSaleClass A Common Stock−7.50K$72.81−$546.1K−12.1%54.7K after
Jul 11, 2022 (view filing)Jul 83 daysKralowetz Donna HildebrandEVP, Chief Accounting OfficerSSaleClass A Common Stock−1.15K$73.16−$84.1K−14.4%6.80K after

Top 10 13F holders, Q2 2023

The largest institutional positions in Syneos Health, Inc. at the end of Q2 2023; share changes are against Q1 2023.

See all 317 holders
Institutions holding SYNH in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc10,283,488$433.3M0.01%−165,675−1.6%Reduced
BlackRock Inc.9,930,430$418.5M0.01%−575,313−5.5%Reduced
Barclays PLC4,664,940$196.6M0.13%+1,604,446+52.4%Added
UBS Oconnor LLC3,342,622$140.9M2.98%+3,342,622New
Elliott Investment Management L.P.SuperinvestorElliott Investment Management3,299,476$139.0M1.66%+3,299,476New
HBK Investments L P3,250,000$137.0M4.35%+3,250,000New
Farallon Capital Management, L.L.C.3,075,000$129.6M0.77%+2,603,000+551.5%Added
State Street Corp2,885,944$121.6M0.01%+31,564+1.1%Added
Glazer Capital, LLC2,352,886$99.2M6.56%+2,352,886New
Two Sigma Advisers, LP2,033,100$85.7M0.22%+1,168,100+135.0%Added